Expression of members of the multidrug resistance protein family in human term placenta

Citation
Mv. St-pierre et al., Expression of members of the multidrug resistance protein family in human term placenta, AM J P-REG, 279(4), 2000, pp. R1495-R1503
Citations number
49
Categorie Soggetti
Physiology
Journal title
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
ISSN journal
03636119 → ACNP
Volume
279
Issue
4
Year of publication
2000
Pages
R1495 - R1503
Database
ISI
SICI code
0363-6119(200010)279:4<R1495:EOMOTM>2.0.ZU;2-R
Abstract
The placenta serves, in part, as a barrier to exclude noxious substances fr om the fetus. In humans, a single-layered syncytium of polarized trophoblas t cells and the fetal capillary endothelium separate the maternal and fetal circulations. P-glycoprotein is present in the syncytiotrophoblast through out gestation, consistent with a protective role that limits exposure of th e fetus to hydrophobic and cationic xenobiotics. We have examined whether m embers of the multidrug resistance protein (MRP) family are expressed in te rm placenta. After screening a placenta cDNA library, partial clones of MRP 1, MRP2, and MRP3 were identified. Immunofluorescence and immunoblotting st udies demonstrated that MRP2 was localized to the apical syncytiotrophoblas t membrane. MRP1 and MRP3 were predominantly expressed in blood vessel endo thelia with some evidence for expression in the apical syncytiotrophoblast. ATP-dependent transport of the anionic substrates dinitrophenyl-glutathion e and estradiol-17-beta-glucuronide was also demonstrated in apical syncyti otrophoblast membranes. Given the cellular distribution of these transporte rs, we hypothesize that MRP isoforms serve to protect fetal blood from entr y of organic anions and to promote the excretion of glutathione/glucuronide metabolites in the maternal circulation.